Clinical trial

OPsumit USers Registry

NCT02126943

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-04-30

PhaseN/A

Study timeline

Study start (actual)2014-04-30Date precision: day

Registry last updated2025-03-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

Opsumit (macitentan)DRUG

Sponsors & collaborators

Actelionlead sponsor

Mapped research locations

CincinnatiOhio, United States4 BostonMassachusetts, United States3 Los AngelesCalifornia, United States3 PhiladelphiaPennsylvania, United States3 PortlandOregon, United States3 PhoenixArizona, United States3 St. PetersburgFlorida, United States3 New YorkNew York, United States2 St LouisMissouri, United States2 MiamiFlorida, United States2 ColumbusOhio, United States2 JacksonvilleFlorida, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02126943 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.